wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q37521403-40D6E301-6B65-49B6-A486-9E4AEB81EB55
Q37521403-40D6E301-6B65-49B6-A486-9E4AEB81EB55
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37521403-40D6E301-6B65-49B6-A486-9E4AEB81EB55
Killing Two Cells with One Stone: Pharmacologic BCL-2 Family Targeting for Cancer Cell Death and Immune Modulation.
P2860
Q37521403-40D6E301-6B65-49B6-A486-9E4AEB81EB55
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37521403-40D6E301-6B65-49B6-A486-9E4AEB81EB55
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
ecbed8a76af4c82cf65dd97faed29d08f41ecc5f
P2860
Phase 1 study of the safety, pharmacokinetics, and antitumour activity of the BCL2 inhibitor navitoclax in combination with rituximab in patients with relapsed or refractory CD20+ lymphoid malignancies